Skip to Main Content
Legislation Search

H.R. 2592: Aviation Medication Transparency Act of 2025

This bill, titled the Aviation Medication Transparency Act of 2025, aims to create a transparent system for airmen regarding the medications they can safely use while maintaining their medical certification for flying. Here’s a breakdown of the key provisions of the bill:

1. Creation of a Medication List

The Federal Aviation Administration (FAA) is required to publish a publicly available list of medications that are considered safe for airmen to take. This list must be accessible on the FAA's website and should be compiled within one year after the bill becomes law.

2. Development Requirements

In creating this list, the FAA must:

  • Consult with various stakeholders, including:
    • The Aeromedical Innovation and Modernization Working Group
    • Union representatives of air traffic controllers
    • The largest organization representing airline pilots
    • Other relevant stakeholders as determined by the task group
  • Ensure the list is comprehensive and user-friendly, particularly for those seeking medical certification.
  • Include guidance on the average recovery time after starting any approved medication.
  • Identify medications deemed unsafe and labeled as "Do Not Issue."
  • Provide a contact method for medical professionals to inquire about the list.
  • Offer explanations for why certain medications are permitted or prohibited.
  • Include additional clarifications as deemed necessary by the FAA.

3. Annual Updates

The FAA must also keep the published list up-to-date by reviewing and refreshing the information at least once a year after the initial publication. This ensures that the list remains relevant with any new findings or changes in medical guidance.

4. Accessibility for Airmen

The medication list is intended to be provided to airmen when they first apply for a medical license and certification, enhancing their understanding of safe medication use while flying.

5. Purpose of the Bill

The overall purpose of the bill is to improve transparency and provide airmen with clear guidance regarding medication use, helping to maintain safety within the aviation industry.

Relevant Companies

None found

This is an AI-generated summary of the bill text. There may be mistakes.

Show More

Sponsors

2 bill sponsors

Actions

3 actions

Date Action
Apr. 02, 2025 Introduced in House
Apr. 02, 2025 Referred to the House Committee on Transportation and Infrastructure.
Apr. 02, 2025 Referred to the Subcommittee on Aviation.

Corporate Lobbying

0 companies lobbying

None found.

* Note that there can be significant delays in lobbying disclosures, and our data may be incomplete.

Potentially Relevant Congressional Stock Trades

No relevant congressional stock trades found.